NXTC (STOCKS)
NextCure, Inc. Common Stock
$12.320000
+0.680000 (+5.84%)
Prev close: $11.640000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Michael S. Richman
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $43.90M
- Employees
- 43
- P/E (TTM)
- -0.56
- P/B (TTM)
- 1.17
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.81 | $-2.47 | +1.6550 | +67.14% |
|
Sep 2025 (Q3)
|
$-3.22 | $-4.06 | +0.8430 | +20.75% |
|
Jun 2025 (Q2)
|
$-11.29 | $-4.71 | -6.5827 | -139.84% |
|
Mar 2025 (Q1)
|
$-4.68 | $-4.90 | +0.2160 | +4.41% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $57.62M |
| Research and Development | $44.92M |
| Other Operating Expenses | $12.69M |
| Operating Income/Loss | -$57.62M |
| Income/Loss From Continuing Operations After Tax | -$55.84M |
| Income/Loss From Continuing Operations Before Tax | -$55.84M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$55.84M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$55.84M |
| Net Income/Loss Available To Common Stockholders, Basic | -$55.84M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$19.65 |
| Diluted Earnings Per Share | -$19.65 |
| Basic Average Shares | 2,842,448 |
| Diluted Average Shares | 2,842,448 |
| Assets | $50.18M |
| Current Assets | $43.75M |
| Noncurrent Assets | $6.44M |
| Fixed Assets | $3.27M |
| Other Non-current Assets | $3.16M |
| Liabilities | $15.24M |
| Current Liabilities | $10.57M |
| Accounts Payable | $2.01M |
| Wages | $851.00K |
| Other Current Liabilities | $7.70M |
| Noncurrent Liabilities | $4.67M |
| Equity | $34.94M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $34.94M |
| Liabilities And Equity | $50.18M |
| Net Cash Flow From Operating Activities | -$49.61M |
| Net Cash Flow From Operating Activities, Continuing | -$49.61M |
| Net Cash Flow From Investing Activities | $25.56M |
| Net Cash Flow From Investing Activities, Continuing | $25.56M |
| Net Cash Flow From Financing Activities | $22.31M |
| Net Cash Flow From Financing Activities, Continuing | $22.31M |
| Net Cash Flow | -$1.75M |
| Net Cash Flow, Continuing | -$1.75M |
| Comprehensive Income/Loss | -$55.83M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$55.83M |
| Other Comprehensive Income/Loss | $17.00K |